In a study by Oliva et al., the concentration of soluble E-selectin was compared between COVID-19 patients with varying clinical disease severity: those admitted or not admitted to intensive care units, those who survived or died, and those who developed thrombosis or those who did not [32]. Here, SELE is linked to deep vein thrombosis.